BCI
KYNB

Brinker Capital Investments’s Kyntra Bio KYNB Stock Holding History

Brinker Capital Investments’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-877
Closed -$761K – 1335
2021
Q1 		$761K Sell
877
-859
-49% -$915K 0.01% 779
2020
Q4 		$1.61M Buy
1,736
+415
+31% +$436K 0.02% 597
2020
Q3 		$1.36M Buy
+1,321
New +$1.42M 0.02% 595
2020
Q1 		– Sell
-4
Closed -$4K – 455
2019
Q4 		$4K Buy
+4
New +$4.08K ﹤0.01% 694

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Brinker Capital Investments's KYNB Position: Q2 2021 in Review

Brinker Capital Investments sold out of Kyntra Bio (KYNB) in Q2 2021, closing a stake of 877 shares — an estimated $761K sold.

Brinker Capital Investments first reported a position in KYNB in Q4 2019 and held it in 4 quarters. The position peaked at $1.61M in Q4 2020. 174 funds tracked by Wall St. Rank hold KYNB as of Q2 2021.

  • Brinker Capital Investments reported no remaining Kyntra Bio position as of Q2 2021 after selling out during the quarter.
  • Brinker Capital Investments sold 877 Kyntra Bio shares in Q2 2021, an estimated $761K.
  • Brinker Capital Investments first reported a position in Kyntra Bio in Q4 2019 and held it in 4 quarters.
  • Brinker Capital Investments's Kyntra Bio position peaked at $1.61M in Q4 2020.
  • 174 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2021.

Based on Brinker Capital Investments's 13F filing for Q2 2021, filed 3 Aug 2021.